Brief: Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update

Fennec Pharmaceuticals

28/02/2022 11:10

Feb 28 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES FISCAL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * QTRLY DILUTED NET LOSS PER COMMON SHARE $0.18
    * EXPECT TO RESUBMIT NEW DRUG APPLICATION (NDA) FOR PEDMARK™
TO
FDA DURING Q1 OF 2022
    * FENNEC PHARMACEUTICALS- BELIEVES CASH AND CASH EQUIVALENTS
ON
HAND AS OF DEC 31, 2021 TO BE SUFFICIENT TO FUND COMPANY'S
PLANNED ACTIVITIES FOR 2022
    * Q4 EARNINGS PER SHARE VIEW $0.75 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7p4FH 
Further company coverage:  FENC.O 

 ((Reuters.Briefs@thomsonreuters.com;))